News
- Author:
- Nick Mulcahy
Publish date: May 15, 2020
Pomalidomide is the first new treatment option approved for Kaposi sarcoma in more than 20 years.
News
- Author:
- Nick Mulcahy
Publish date: May 1, 2020
Is it a silver lining to the coronavirus pandemic?
News
- Author:
- Nick Mulcahy
Publish date: April 23, 2020
Sacituzumab govitecan-hziy (Trodelvy) is now approved for adults with metastatic triple-negative breast cancer who received at least two prior ther...
News
- Author:
- Nick Mulcahy
Publish date: April 22, 2020
Pre-operative endocrine therapy produced measurable radiographic changes in postmenopausal women with estrogen re...
News
- Author:
- Nick Mulcahy
Publish date: April 20, 2020
The FDA approved tucatinib in combination with trastuzumab and capecitabine for adults with advanced unresectable...
News
- Author:
- Nick Mulcahy
Publish date: April 13, 2020
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
News
- Author:
- Nick Mulcahy
Publish date: April 10, 2020
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
News
- Author:
- Nick Mulcahy
Publish date: April 6, 2020
Luspatercept has been approved by the FDA to treat anemia in patients with myelodysplastic syndromes.
News
- Author:
- Nick Mulcahy
Publish date: April 2, 2020
A cancer center in China has so far managed to protect all patients and staff from COVID-19.
News
- Author:
- Nick Mulcahy
Publish date: March 30, 2020
Durvalumab is approved in combination with etoposide and either carboplatin or cisplatin as first-line treatment ...
News
- Author:
- Nick Mulcahy
Publish date: March 27, 2020
Is it a silver lining to the coronavirus pandemic?
News
- Author:
- Nick Mulcahy
Publish date: March 17, 2020
Investigators find fault with an assay used to determine which triple-negative breast cancer patients are eligible to receive atezolizumab.
News
- Author:
- Nick Mulcahy
Publish date: March 11, 2020
The FDA granted accelerated approval for the combination of nivolumab and ipilimumab to treat patients with hepat...
News
- Author:
- Nick Mulcahy
Publish date: March 2, 2020
Isatuximab is approved for use in combination with pomalidomide and dexamethasone to treat adults with relapsed/r...
